北京康立生

Beijing Kanglisheng is a specialized pharmaceutical research and development company headquartered in Beijing, China. Founded in 2009, the firm operates primarily as a Contract Research Organization (CRO) focusing on the development of high-end generic drugs and the synthesis of complex pharmaceutical impurities. The company offers a broad range of services including chemical process development, pharmaceutical analysis, and consistency evaluation to ensure generic products meet regulatory standards. Kanglisheng is recognized for its extensive catalog of reference standards and its ability to provide technical solutions for challenging chemical syntheses. Their facilities include advanced R&D laboratories and pilot-scale manufacturing units designed to support the pharmaceutical industry's needs from early development through to commercialization.